Accredited Educational Activities

CLICK ON STATES TO SEE LIVE ACTIVITIES

ONLINE ACTIVITIES

Jul
30
Thu
No Eyes Left Behind: Diabetic Retinopathy Clinical Essentials Related to Prevalence and Risk, Pathobiology, Detection and Treatment
Jul 30 2020 @ 12:00 am – Jul 30 2021 @ 11:45 pm

No Eyes Left Behind: Diabetic Retinopathy
Clinical Essentials Related to Prevalence and Risk, Pathobiology, Detection and Treatment

VIEW ACTIVITY

FACULTY

A. Paul Chous, MA, OD, FAAO
Chief of Optometry
Chous Eye Care Associates
Tacoma, WA
Adjunct Instructor
Nova Southeastern University College of Optometry
Optometrist and Diabetes Educator
Chous Eye Care Associates
Tacoma, WA

PROGRAM OVERVIEW

This online activity is focused on the management of patients with diabetic retinopathy.

TARGET AUDIENCE

This activity is designed to meet the educational needs of retina specialists, ophthalmologists, optometrists who manage patients with DR, DME, and AMD.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Explain the importance of proper eye care in patients who have or are at risk for developing diabetic retinopathy (DR)
  • Describe the progressive visual changes that can be experienced by those who have or are at risk for and those who have been treated for DR, thereby emphasizing the importance of proper eye care
  • Establish collaborative strategies that promote team-based communication and patient continuity of care to provide appropriate eye-care delivery for patients who have or are at risk for developing DR
  • Define the pathogenic changes observed with DR that would be best managed by team-based approaches for appropriate eye-care delivery
  • Evaluate the efficacy and safety of currently available treatments, including panretinal photocoagulation (PRP) and agents that target the VEGF pathway, used to manage patients with DR

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this web-based live activity for a maximum of 1.25 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the web-based live activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with DR.
Credits: 1.25 ANCC Contact Hour(s).

CNE ACCREDITATION STATEMENT:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.25 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

A.Paul Chous, MA, OD, FAAO, has received royalties and consulting fees from EyePromise. He is on the speaker’s bureaus for EyePromise, Regeneron, Genentech, and Zeiss. Dr. Chous has received fees for Non-CME/CE Services Received Directly from Regeneron and Genentech.

Staff, Planners, and Managers
The independent reviewers, staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests:

CME Content Review
The content of this activity was independently peer reviewed. The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse. The reviewer has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
Nicole Longo, DO, FACOI, Director of Medical and Scientific Services of Med Learning Group, has nothing to disclose.
Melissa Johnson, Senior Program Manager of Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
Brianna Hanson, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures;
2. Participate in the enduring activity; and
3. Complete pre-and-post surveys and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

RELEASE DATE: July 30, 2020

EXPIRATION DATE: July 30, 2021

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

VIEW ACTIVITY

Aug
31
Mon
Looking through the 2020 Lens: Understanding Diabetic Retinopathy and Current Evidence for Improved Care
Aug 31 2020 @ 6:31 pm – Aug 31 2021 @ 7:31 pm

 

Looking through the 2020 Lens: Understanding Diabetic Retinopathy and Current Evidence for Improved Care

FACULTY

Allen C. Ho, MD, FACS
Wills Eye Hospital Attending Surgeon and Director of Retina Research
Professor of Ophthalmology
Thomas Jefferson University
Mid Atlanta Retina

PROGRAM OVERVIEW

This online activity is focused on management of patients with diabetic retinopathy.

TARGET AUDIENCE

This activity is designed to meet the educational needs of retina specialists, ophthalmologists, and optometrists who manage patients with DR, DME, and AMD.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Explain the importance of proper eye care in patients who have or are at risk for developing diabetic retinopathy (DR)
  • Describe the progressive visual changes that can be experienced by those who have, are at risk for, or have been treated for DR, thereby emphasizing the importance of proper eye care
  • Establish collaborative strategies that promote team-based communication and patient continuity of care to provide appropriate eye-care delivery for patients who have or are at risk for developing DR
  • Define the pathogenic changes observed with DR, which would be best managed by team-based approaches for appropriate eye-care delivery
  • Evaluate the efficacy and safety of currently available treatments, including panretinal photocoagulation (PRP) and agents that target the VEGF pathway, used to manage patients with DR

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 credit™Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with DR. Credits: 1.0 ANCC Contact Hour.

CNE ACCREDITATION STATEMENT:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Allen Ho discloses the following:
– He is a consultant/advisor for Adverum, Aerie, AGTC, Alcon Laboratories, Aldeyra, Allergan, Apellis, Asclepix, Beaver-Visitec International, BioTime, Chengdu Kanghong Biotechnology, Genentech, Graybug, Gyroscope, IRIDEX, Iveric/Ophthotech, Johnson & Johnson, Lineage/BioTime, Notal, ONL, Optovue, PanOptica, Regeneron and RegenXBio.
– He has received grants from Aerie, AGTC, Alcon Laboratories, Aldeyra, Allergan, Apellis, BioTime, Chengdu Kanghong Biotechnology, Genetech, Gemini, Graybug, Gyroscope, Iveric/Ophthotech, Johnson & Johnson, Lineage/BioTime, Lumithera, National Eye Institute, Novartis, Optovue, ProQR, Regeneron, RegenXBio and Sanofi.
– He has ownership in Covalent Medical, ONL and PanOptica.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
Nicole Longo, DO, FACOI, Director of Medical and Scientific Services of Med Learning Group, has nothing to disclose.
Melissa A Johnson, Senior Program Manager of Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures;
  2. Participate in the enduring activity; and
  3. Complete pre-and-post surveys and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision‐making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

RELEASE DATE: August 31, 2020

EXPIRATION DATE: August 31, 2021

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

 

Sep
1
Tue
Infographic Virtual Pathways: A Look Past the Lens: Identifying and Diagnosing Diabetic Retinopathy to Improve Eye Care for Patients with Diabetes
Sep 1 2020 @ 7:21 am – Sep 2 2021 @ 8:21 am

A Look Past the Lens: Identifying and Diagnosing Diabetic Retinopathy to Improve Eye Care for Patients with Diabetes

View Activity Toolkit Create your complimentary poster

FACULTY

Charles C. Wykoff, MD, PhD
Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute and Houston Methodist Hospital
Houston, Texas

PROGRAM OVERVIEW

This online activity is focused on the team involved in the management of patients with diabetic retinopathy (DR).

TARGET AUDIENCE

This activity is designed to meet the educational needs of optometrists and ophthalmologists who diagnose and manage patients with DR or who are at risk for developing DR.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Review the importance of proper eye care in patients with diabetes
  • Discuss the relationship between the development of diabetes and eye complications to encourage better patient self-care
  • Integrate strategies that focus on appropriate assessment and referral of patients with DR to improve patient communication and team-based collaborative care
  • Evaluate the efficacy and safety of currently available agents that target the VEGF pathway used to manage patients with DR and diabetic macular edema (DME) as they relate to the pathophysiology of diabetic eye conditions and study populations

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this web-based activity for a maximum of 0.75 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with DR.
CNE Credits: 0.75 ANCC Contact Hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF FINANCIAL RELATIONSHIPS

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Charles Wykoff, MD, PhD, serves on the speakers’ bureau for Regeneron; is a consultant for Allergan, Bayer, Genentech, Novartis, Regeneron and Roche; and receives research support from Allergan, Genentech, Novartis, Regeneron, and Roche.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
Marcello Morgan, MD, MPH, Director of Medical and Scientific Services, has nothing to disclose.
Ana Maria Albino, Program Manager of Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes of Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures;
2. Participate in the enduring activity; and
3. Complete pre-and-post surveys and evaluation.
You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

RELEASE DATE: February 28, 2020

EXPIRATION DATE: February 28, 2021

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

A Virtual Reality Learning Experience: Integrating GLP-1 Receptor Agonists into T2DM Practice—Why, When, and How

Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Scroll to Top

Clinician Scientific & Educational Resources

The RELIEF Clinical Toolkit is an online tool that aims to provide clinicians with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for diabetic retinopathy (DR) in patients with diabetes who have or are at risk for developing DR. Click on one of the options below to learn more about DR.

This activity is provided by Med Learning Group. This activity is co-provided by Ultimate Medical Academy/CCM.
This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | Diabetic Retinopathy | All Rights Reserved | Website by Divigner

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX